C-reactive protein and arteriosclerosis
- PMID: 24976688
- PMCID: PMC4058278
- DOI: 10.1155/2014/646817
C-reactive protein and arteriosclerosis
Similar articles
-
Deposition of modified or native C-reactive protein in atherosclerotic arteries?Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):1173-4. doi: 10.1161/01.atv.20.4.1173. Arterioscler Thromb Vasc Biol. 2000. PMID: 10764690 No abstract available.
-
C-reactive protein and atherogenesis: new insights from established animal models.Am J Pathol. 2005 Oct;167(4):923-5. doi: 10.1016/S0002-9440(10)61182-0. Am J Pathol. 2005. PMID: 16192628 Free PMC article. No abstract available.
-
C-reactive protein: a surrogate marker for atherosclerosis.Curr Opin Lipidol. 2004 Jun;15(3):365-7. doi: 10.1097/00041433-200406000-00019. Curr Opin Lipidol. 2004. PMID: 15166795 No abstract available.
-
C-reactive protein: a surrogate risk marker or mediator of atherothrombosis?Am J Physiol Regul Integr Comp Physiol. 2003 Nov;285(5):R1250-2. doi: 10.1152/ajpregu.00227.2003. Am J Physiol Regul Integr Comp Physiol. 2003. PMID: 14557240 Review. No abstract available.
-
C-reactive protein and atherothrombosis--beyond a biomarker: an actual partaker of lesion formation.Am J Physiol Regul Integr Comp Physiol. 2003 Nov;285(5):R1253-6; discussion R1257-8. doi: 10.1152/ajpregu.00170.2003. Am J Physiol Regul Integr Comp Physiol. 2003. PMID: 14557241 Review. No abstract available.
Cited by
-
New Insights in Prevention and Treatment of Cardiovascular Disease.Int J Environ Res Public Health. 2022 Feb 21;19(4):2475. doi: 10.3390/ijerph19042475. Int J Environ Res Public Health. 2022. PMID: 35206661 Free PMC article.
-
C-Reactive Protein Stimulates Nicotinic Acetylcholine Receptors to Control ATP-Mediated Monocytic Inflammasome Activation.Front Immunol. 2018 Jul 30;9:1604. doi: 10.3389/fimmu.2018.01604. eCollection 2018. Front Immunol. 2018. PMID: 30105015 Free PMC article.
-
Negative regulation of ATP-induced inflammasome activation and cytokine secretion by acute-phase proteins: A mini review.Front Pharmacol. 2022 Aug 29;13:981276. doi: 10.3389/fphar.2022.981276. eCollection 2022. Front Pharmacol. 2022. PMID: 36105198 Free PMC article. Review.
-
Targeting C-Reactive Protein by Selective Apheresis in Humans: Pros and Cons.J Clin Med. 2022 Mar 23;11(7):1771. doi: 10.3390/jcm11071771. J Clin Med. 2022. PMID: 35407379 Free PMC article. Review.
-
Successful Treatment of a 39-Year-Old COVID-19 Patient with Respiratory Failure by Selective C-Reactive Protein Apheresis.Am J Case Rep. 2021 Aug 5;22:e932964. doi: 10.12659/AJCR.932964. Am J Case Rep. 2021. PMID: 34351878 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials